C88.3 Immunoproliferative small intestinal disease

Name of the Condition

• Immunoproliferative small intestinal disease
• A rare malignant disorder involving the uncontrolled proliferation of immune cells in the small intestine, often associated with abnormal immunoglobulin production.

Summary

Immunoproliferative small intestinal disease is characterized by the abnormal growth of lymphoid tissue in the small intestine, leading to symptoms related to intestinal dysfunction and systemic effects. The condition may involve the overproduction of immunoglobulins or other immune-related proteins, contributing to tissue damage and organ involvement.

Causes

The exact causes are not fully understood, but genetic mutations in immune cells are believed to drive the abnormal proliferation. Chronic infections or inflammatory processes in the gastrointestinal tract may also play a role in triggering the disease.

Risk Factors

• Age, with a higher prevalence in young to middle-aged adults.
• Ethnic background, with increased incidence in certain populations (e.g., Mediterranean or Middle Eastern regions).
• Chronic gastrointestinal infections or inflammatory conditions.
• Family history of lymphoid malignancies.

Symptoms

• Abdominal pain, diarrhea, or weight loss.
• Malabsorption leading to nutritional deficiencies.
• Enlarged lymph nodes or spleen.
• Fatigue or weakness.
• Recurrent infections due to impaired immunity.
• Fever or night sweats.

Diagnosis

Diagnosis typically involves a physical exam, blood tests (to detect abnormal immunoglobulins or markers), imaging (e.g., CT or MRI), and a biopsy of intestinal tissue to confirm malignancy and characterize the cellular proliferation.

Treatment Options

Treatment may include chemotherapy to target abnormal immune cells, immunomodulatory therapies, or surgery to address intestinal complications. Supportive care, such as nutritional supplementation, may also be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the extent of disease and response to treatment. Regular follow-up with imaging and blood tests is recommended to monitor for recurrence or progression.

Complications

• Severe malabsorption leading to malnutrition.
• Intestinal obstruction or perforation.
• Increased risk of infections due to immune dysfunction.
• Potential spread to other organs or lymph nodes.

Lifestyle & Prevention

Maintaining a balanced diet and managing underlying gastrointestinal conditions may help reduce risk. Avoiding known triggers, such as chronic infections, is also advisable.

When to Seek Professional Help

Seek medical attention for persistent abdominal symptoms, unexplained weight loss, or signs of infection, such as fever or fatigue.

Tips for Medical Coders

Document the specific site (small intestine) and any associated immunoglobulin abnormalities to support accurate coding. Ensure clinical documentation aligns with the diagnosis and includes details on diagnostic tests or treatments performed.